Concentra Group Holdings Parent, Inc. (CON)
| Market Cap | 3.39B +23.5% |
| Revenue (ttm) | 2.23B +15.5% |
| Net Income | 175.14M +13.7% |
| EPS | 1.37 +5.2% |
| Shares Out | 127.96M |
| PE Ratio | 19.43 |
| Forward PE | 17.02 |
| Dividend | $0.25 (0.94%) |
| Ex-Dividend Date | May 19, 2026 |
| Volume | 486,102 |
| Open | 26.40 |
| Previous Close | 26.11 |
| Day's Range | 26.33 - 26.74 |
| 52-Week Range | 18.55 - 26.74 |
| Beta | n/a |
| Analysts | Strong Buy |
| Price Target | 31.71 (+19.71%) |
| Earnings Date | May 7, 2026 |
About CON
Concentra Group Holdings Parent, Inc. provides occupational health services in the United States. The company operates in three segments: Occupational Health centers, Onsite health clinics, and Other business. It offers occupational health services, including workers compensation, employer, and consumer health services; and employer-sponsored primary care services at workplace, including mobile health and episodic specialty testing services. It also operates Concentra Telemed, a telemedicine platform for the treatment of work-related injuries a... [Read more]
Financial Performance
In 2025, CON's revenue was $2.16 billion, an increase of 13.85% compared to the previous year's $1.90 billion. Earnings were $164.17 million, a decrease of -1.30%.
Financial StatementsAnalyst Summary
According to 7 analysts, the average rating for CON stock is "Strong Buy." The 12-month stock price target is $31.71, which is an increase of 19.71% from the latest price.
News
Concentra initiated with a Buy at Goldman Sachs
Goldman Sachs analyst Scott Fidel initiated coverage of Concentra (CON) with a Buy rating and $30 price target The company is a the leading pure-play occupational health platform that can…
Concentra price target raised to $31 from $28 at BofA
BofA raised the firm’s price target on Concentra (CON) to $31 from $28 and keeps a Buy rating on the shares after having hosted Concentra’s team at the BofA Healthcare…
Concentra price target raised to $32 from $29 at Deutsche Bank
Deutsche Bank raised the firm’s price target on Concentra (CON) to $32 from $29 and keeps a Buy rating on the shares.
Concentra Group Holdings Parent Earnings Call Transcript: Q1 2026
Q1 2026 saw double-digit revenue and EBITDA growth, driven by strong workers' compensation volumes, successful acquisition integrations, and improved margins. Guidance for 2026 was raised across revenue, EBITDA, and Free Cash Flow, with continued focus on expansion and operational efficiency.
Concentra Group Holdings Parent Earnings release: Q1 2026
Concentra Group Holdings Parent released its Q1 2026 earnings on May 8, 2026, summarizing the period's financial results.
Concentra Group Holdings Parent Quarterly report: Q1 2026
Concentra Group Holdings Parent has published its Q1 2026 quarterly earnings report on May 8, 2026.
Concentra Group Holdings Parent Slides: Q1 2026
Concentra Group Holdings Parent has posted slides in relation to its Q1 2026 quarterly earnings report, which was published on May 8, 2026.
Concentra Group Holdings Parent, Inc. Announces Results for Its First Quarter Ended March 31, 2026, Cash Dividend, and Raised FY 2026 Guidance
ADDISON, Texas--(BUSINESS WIRE)--Concentra Group Holdings Parent, Inc. (“Concentra,” the “Company,” “we,” “us,” or “our”) (NYSE: CON), the nation's largest provider of occupational health services by ...
Concentra CMO Anderson to retire
Concentra (CON) Group announced that Dr. John Anderson, executive vice president and Chief Medical Officer, will retire from Concentra at the end of the year. Dr. Anderson plans to advise…
Concentra Chief Medical Officer Dr. Anderson to Retire After 33 Years
ADDISON, Texas--(BUSINESS WIRE)--Concentra Group Holdings Parent, Inc. (“Concentra,” the “Company,” “we,” “us,” or “our”) (NYSE: CON), the nation's largest provider of occupational health services by ...
Concentra to Announce First Quarter 2026 Results on Thursday, May 7, 2026
ADDISON, Texas--(BUSINESS WIRE)--Concentra® Group Holdings Parent, Inc. (“Concentra”) (NYSE: CON) will release the financial results for its first quarter ended March 31, 2026, on Thursday, May 7, 202...
Concentra Group Holdings Parent Proxy statement: Proxy Filing
Concentra Group Holdings Parent filed a proxy statement on March 17, 2026, providing details for shareholder voting and corporate governance matters.
Concentra Group Holdings Parent Proxy statement: Proxy Filing
Concentra Group Holdings Parent filed a proxy statement on March 17, 2026, providing details for shareholder voting and corporate governance matters.
Concentra Group Holdings Parent Earnings Call Transcript: Q4 2025
Revenue and Adjusted EBITDA exceeded guidance in 2025, driven by strong organic growth, successful acquisitions, and cost efficiencies. 2026 guidance projects continued growth, margin stability, and robust capital deployment, with a focus on de novos and small M&A.
Concentra Group Holdings Parent Annual report: Q4 2025
Concentra Group Holdings Parent has published its Q4 2025 annual report on February 27, 2026.
Concentra Group Holdings Parent Earnings release: Q4 2025
Concentra Group Holdings Parent released its Q4 2025 earnings on February 27, 2026, summarizing the period's financial results.
Concentra Group Holdings Parent Slides: Q4 2025
Concentra Group Holdings Parent has posted slides in relation to its Q4 2025 quarterly earnings report, which was published on February 27, 2026.
Concentra Group Holdings Parent, Inc. Announces Fourth Quarter and Year Ended 2025 Results
ADDISON, Texas--(BUSINESS WIRE)--Concentra Group Holdings Parent, Inc. (“Concentra,” the “Company,” “we,” “us,” or “our”) (NYSE: CON), the nation's largest provider of occupational health services by ...
Concentra price target raised to $31 from $30 at RBC Capital
RBC Capital raised the firm’s price target on Concentra (CON) to $31 from $30 and keeps an Outperform rating on the shares. The firm cites the company’s above-consensus Q4 pre-announcement…
Concentra reports preliminary Q4 adjusted EPS 28c, consensus 23c
Reports preliminary Q4 revenue $539.1M, consensus $532M. “The 2025 fiscal year was another transformative year for Concentra (CON) as we continued to provide superior outcomes and exceptional experien...
Concentra Announces Preliminary 2025 Financial Results, Provides 2026 Financial Guidance, and Announces Q4 2025 Earnings Call Date
ADDISON, Texas--(BUSINESS WIRE)--Concentra Group Holdings Parent, Inc. (“Concentra,” the “Company,” “we,” “us,” or “our”) (NYSE: CON), the nation's largest provider of occupational health services by ...
Concentra opens new medical center in Georgia
Concentra (CON) announced the opening of a new medical center in Tucker, Georgia.
Concentra Expands to Tucker, Georgia
ADDISON, Texas--(BUSINESS WIRE)--Concentra® (NYSE: CON), the nation's leader in occupational medicine, today announced the opening of a new medical center in Tucker, Georgia. The medical center, Conce...
Concentra Acquires Reliant Immediate Care from MBI Industrial Medicine
ADDISON, Texas--(BUSINESS WIRE)--Concentra®, the nation's leader in occupational medicine, today announced the acquisition of the assets of Reliant Immediate Care in California. Reliant Immediate Care...
Concentra Group Holdings Parent Transcript: 44th Annual J.P. Morgan Healthcare Conference
The company reinforced its leadership in occupational health, reporting strong revenue and EBITDA growth, high patient satisfaction, and successful integration of recent acquisitions. Strategic focus remains on organic growth, disciplined M&A, and flexible capital allocation, with positive rate and volume trends expected to continue.